Literature DB >> 17556024

High serum levels of BAFF, APRIL, and TACI in common variable immunodeficiency.

Adina K Knight1, Lin Radigan, Thomas Marron, Allison Langs, Li Zhang, Charlotte Cunningham-Rundles.   

Abstract

Common variable immunodeficiency (CVID) is characterized by low levels of immune globulins and lack of antibody. Mutations in transmembrane activator and calcium-modulating cyclophilin ligand (TACI), are found in 8-10%, associated with autoimmunity and splenomegaly. Some patients with mutations had increased serum levels of TACI. Because of this, and the prevalence of autoimmunity, splenomegaly, and lymphadenopathy, we quantitated levels of TACI ligands, a proliferation inducing ligand (APRIL) and B cell activating factor (BAFF) and TACI in serum of 77 patients. CVID subjects had markedly increased serum levels of BAFF (p<0.0001), APRIL (p<0.0001), and TACI (p=0.001) but there was no relationship between levels and autoimmunity, lymphadenopathy, splenomegaly, B cell numbers, or mutations in TACI. Peripheral blood mononuclear cells of CVID subjects had increased levels of BAFF mRNA. We conclude that increased constitutive production and/or underlying immuno-regulatory or inflammatory conditions lead to enhanced release of ligands; however, the biological result remains unclear.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17556024      PMCID: PMC2491330          DOI: 10.1016/j.clim.2007.04.012

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  71 in total

1.  Granulomatous disease in common variable immunodeficiency.

Authors:  L J Mechanic; S Dikman; C Cunningham-Rundles
Journal:  Ann Intern Med       Date:  1997-10-15       Impact factor: 25.391

2.  A defect in the early phase of T-cell receptor-mediated T-cell activation in patients with common variable immunodeficiency.

Authors:  M B Fischer; I Hauber; H Eggenbauer; V Thon; E Vogel; E Schaffer; J Lokaj; J Litzman; H M Wolf; J W Mannhalter
Journal:  Blood       Date:  1994-12-15       Impact factor: 22.113

3.  Analysis on the association of human BLYS (BAFF, TNFSF13B) polymorphisms with systemic lupus erythematosus and rheumatoid arthritis.

Authors:  A Kawasaki; N Tsuchiya; T Fukazawa; H Hashimoto; K Tokunaga
Journal:  Genes Immun       Date:  2002-11       Impact factor: 2.676

4.  BLyS and APRIL form biologically active heterotrimers that are expressed in patients with systemic immune-based rheumatic diseases.

Authors:  Viktor Roschke; Svetlana Sosnovtseva; Christopher D Ward; June S Hong; Rodger Smith; Vivian Albert; William Stohl; Kevin P Baker; Stephen Ullrich; Bernardetta Nardelli; David M Hilbert; Thi-Sau Migone
Journal:  J Immunol       Date:  2002-10-15       Impact factor: 5.422

5.  Lack of specific antibody response in common variable immunodeficiency (CVID) associated with failure in production of antigen-specific memory T cells. MRC Immunodeficiency Group.

Authors:  I Kondratenko; P L Amlot; A D Webster; J Farrant
Journal:  Clin Exp Immunol       Date:  1997-04       Impact factor: 4.330

6.  Loss of TACI causes fatal lymphoproliferation and autoimmunity, establishing TACI as an inhibitory BLyS receptor.

Authors:  Dhaya Seshasayee; Patricia Valdez; Minhong Yan; Vishva M Dixit; Daniel Tumas; Iqbal S Grewal
Journal:  Immunity       Date:  2003-02       Impact factor: 31.745

7.  Homozygous loss of ICOS is associated with adult-onset common variable immunodeficiency.

Authors:  Bodo Grimbacher; Andreas Hutloff; Michael Schlesier; Erik Glocker; Klaus Warnatz; Ruth Dräger; Hermann Eibel; Beate Fischer; Alejandro A Schäffer; Hans W Mages; Richard A Kroczek; Hans H Peter
Journal:  Nat Immunol       Date:  2003-02-10       Impact factor: 25.606

Review 8.  BAFF: a fundamental survival factor for B cells.

Authors:  Fabienne Mackay; Jeffrey L Browning
Journal:  Nat Rev Immunol       Date:  2002-07       Impact factor: 53.106

Review 9.  BAFF: a novel therapeutic target for autoimmunity.

Authors:  Susan L Kalled
Journal:  Curr Opin Investig Drugs       Date:  2002-07

10.  G-CSF-stimulated neutrophils are a prominent source of functional BLyS.

Authors:  Patrizia Scapini; Bernardetta Nardelli; Gianpaolo Nadali; Federica Calzetti; Giovanni Pizzolo; Cesare Montecucco; Marco A Cassatella
Journal:  J Exp Med       Date:  2003-02-03       Impact factor: 14.307

View more
  35 in total

1.  Constitutive overexpression of BAFF in autoimmune-resistant mice drives only some aspects of systemic lupus erythematosus-like autoimmunity.

Authors:  William Stohl; Noam Jacob; Shunhua Guo; Laurence Morel
Journal:  Arthritis Rheum       Date:  2010-08

Review 2.  How I treat common variable immune deficiency.

Authors:  Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2010-03-23       Impact factor: 22.113

3.  Role of B cells in common variable immune deficiency.

Authors:  Sam Ahn; Charlotte Cunningham-Rundles
Journal:  Expert Rev Clin Immunol       Date:  2009-09       Impact factor: 4.473

4.  CVID-associated TACI mutations affect autoreactive B cell selection and activation.

Authors:  Neil Romberg; Nicolas Chamberlain; David Saadoun; Maurizio Gentile; Tuure Kinnunen; Yen Shing Ng; Manmeet Virdee; Laurence Menard; Tineke Cantaert; Henner Morbach; Rima Rachid; Natalia Martinez-Pomar; Nuria Matamoros; Raif Geha; Bodo Grimbacher; Andrea Cerutti; Charlotte Cunningham-Rundles; Eric Meffre
Journal:  J Clin Invest       Date:  2013-09-24       Impact factor: 14.808

5.  BAFF-driven B cell hyperplasia underlies lung disease in common variable immunodeficiency.

Authors:  Paul J Maglione; Gavin Gyimesi; Montserrat Cols; Lin Radigan; Huaibin M Ko; Tamar Weinberger; Brian H Lee; Emilie K Grasset; Adeeb H Rahman; Andrea Cerutti; Charlotte Cunningham-Rundles
Journal:  JCI Insight       Date:  2019-03-07

6.  Replacing mouse BAFF with human BAFF does not improve B-cell maturation in hematopoietic humanized mice.

Authors:  Julie Lang; Bicheng Zhang; Margot Kelly; Jacob N Peterson; Jacob Barbee; Brian M Freed; James P Di Santo; Jennifer L Matsuda; Raul M Torres; Roberta Pelanda
Journal:  Blood Adv       Date:  2017-12-19

7.  TNF receptor superfamily member 13b (TNFRSF13B) hemizygosity reveals transmembrane activator and CAML interactor haploinsufficiency at later stages of B-cell development.

Authors:  Neil Romberg; Manmeet Virdee; Nicolas Chamberlain; Tyler Oe; Jean-Nicolas Schickel; Tiffany Perkins; Tineke Cantaert; Rima Rachid; Sally Rosengren; Regina Palazzo; Raif Geha; Charlotte Cunningham-Rundles; Eric Meffre
Journal:  J Allergy Clin Immunol       Date:  2015-06-19       Impact factor: 10.793

8.  Reduced BAFF-R and increased TACI expression in common variable immunodeficiency.

Authors:  Rita R Barbosa; Susana L Silva; Sara P Silva; Alcinda C Melo; M Conceição Pereira-Santos; João T Barata; Lennart Hammarström; Marília Cascalho; Ana E Sousa
Journal:  J Clin Immunol       Date:  2014-05-09       Impact factor: 8.317

9.  B-cell activating factor (BAFF) is elevated in chronic granulomatous disease.

Authors:  Kabir Matharu; Kol A Zarember; Beatriz E Marciano; Douglas B Kuhns; Christine Spalding; Mary Garofalo; Thomas Dimaggio; Tyra Estwick; Chiung-Yu Huang; Danielle Fink; Debra L Priel; Thomas A Fleisher; Steven M Holland; Harry L Malech; John I Gallin
Journal:  Clin Immunol       Date:  2013-05-22       Impact factor: 3.969

10.  New targets of PS-341: BAFF and APRIL.

Authors:  Wuping Li; Juan Li; Chang Su; Wai Yi Zou; Shaokai Luo
Journal:  Med Oncol       Date:  2009-05-19       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.